 | |
Native name | 小野薬品工業 |
|---|---|
| Company type | Public ( K.K) |
| TYO: 4528 | |
| ISIN | JP3197600004 |
| Industry | Pharmaceuticals |
| Founded | 1717 as Fushimiya Ichibei apothecary |
| Founder | Ichibei Ono I |
| Headquarters |
Chuo-ku, Osaka, 541-8564 , Japan |
Area served | Worldwide |
Key people | Gyo Sagara ( President and CEO) |
| Products |
|
| Revenue | 
USD 6.3 billion (
FY 2023) |
| USD 848.1 million (FY 2023) | |
Number of employees | 3,687 (2023) |
| Website | Official website |
| Footnotes / references [1] [2] [3] | |
Ono Pharmaceutical Co., Ltd. (小野薬品工業株式会社, Ono Yakuhin Kōgyō Kabushiki-gaisha) is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., [4] and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. [5]
Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono ( Japanese: 小野市兵衛) started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. ( Japanese: 小野薬品工業株式会社) in 1948. [6]
Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. [7]
Nivolumab, the cancer drug based on the research of Prof.Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. [8]
In 2024, Harvard University and Ono Pharmaceutical (ONO) entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. [9]
See also
References
- ^ "Company Profile". Ono Pharmaceutical. Retrieved January 30, 2019.
- ^ "Company Profile". Nikkei Asian Review. Nikkei Inc. Retrieved January 30, 2019.
- ^ "About the company". Financial Times. Retrieved January 30, 2019.
- ^ Ono Pharmaceutical - Manufacturing
- ^ Ono Pharmaceutical - Research & Development
- ^ P. Reed Maurer (January 25, 2013). They Do Well Who Do Good: Insights into Japan's Pharmaceutical Industry. p. 132. ISBN 978-1-4669-5347-5.
- ^ "Company Overview of Ono Pharmaceutical Co., Ltd". bloomberg.com. Retrieved October 4, 2018.
- ^ "Spotlight on New Cancer Immunotherapy: Ono Pharmaceutical's Opdivo". Nippon.com. February 9, 2016. Retrieved October 4, 2018.
- ^ "Harvard partners with Ono Pharma to accelerate development of novel therapeutics". TechTransferCentral. March 18, 2024.
External links
- Official site (in English)
